References
Fischer U, Jänicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10:76–100. doi:10.1038/sj.cdd.4401160
Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384:201–232. doi:10.1042/BJ20041142
Kroemer G (2003) Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 304:433–435. doi:10.1016/S0006-291X(03)00614-4
Lavrik I, Golks A, Krammer PH (2005) Death receptor signaling. J Cell Sci 118:265–267. doi:10.1242/jcs.01610
Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99–104. doi:10.1038/sj.cdd.4400476
Lauber K, Bohn E, Kröber SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G, Wesselborg S (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717–730. doi:10.1016/S0092-8674(03)00422-7
Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang H-Z (2008) Tumor-specific adenovirus-mediated Puma gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Breast Cancer Res Treat [Epub ahead of print] PMID: 18791823
Yeruva L, Abiodun E, Carper SW (2008) Methyl jasmonate decreases membrane fluidity and induces apoptosis through tumor necrosis factor receptor 1 in breast cancer cells. Anticancer Drugs 19:766–776. doi:10.1097/CAD.0b013e32830b5894
Nizamutdinova IT, Lee GW, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ (2008) Tanshione I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. Int J Oncol 33:485–491
Kumar A, D’Souza SS, Gaonkar SL, Rai KML, Salimath BP (2008) Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivatives. Invest New Drugs 26:425–435. doi:10.1007/s10637-008-9116-5
Cui Q, Yu J-h, Wu J-n, Tashiro S-i, Onodera S, Minami M, Ikejima T (2007) p53-mediated cell cycle arrest and apoptosis through a caspase-3-independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin 28:1057–1066. doi:10.1111/j.1745-7254.2007.00588.x
Hsuuw YD, Chan WH (2007) Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann N Y Acad Sci 1095:428–440. doi:10.1196/annals.1397.046
Zhang GP, Lu YY, Lv JC, Ou HJ (2006) Effect of ursolic acid on caspase-3 and PARP expression of human MCF-7 cells. Zhongguo Zhong Yao Za Zhi 31:141–144
Yang HL, Chen CS, Chang WH, Lu FJ, Lai YC, Chen CC, Hseu TH, Kuo CT, Hseu YC (2006) Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett 23:215–227. doi:10.1016/j.canlet.2005.02.004
Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K (2004) Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 200:223–234. doi:10.1002/jcp.20014
Engels IH, Totzke G, Fischer U, Schulze-Osthoff K, Jänicke RU (2005) Caspase-10 sensitizes breast carcinoma cells to TRAIL-induced but not tumor necrosis factor-induced apoptosis in a caspase-3-dependent manner. Mol Cell Biol 25:2808–2818. doi:10.1128/MCB.25.7.2808-2818.2005
Jänicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357–9360. doi:10.1074/jbc.273.16.9357
Jänicke RU, Ng P, Sprengart ML, Porter AG (1998) Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273:15540–15545. doi:10.1074/jbc.273.25.15540
Jänicke RU, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG (2001) Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 20:5043–5053. doi:10.1038/sj.onc.1204659
Essmann F, Engels IH, Totzke G, Schulze-Osthoff K, Jänicke RU (2004) Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Cancer Res 64:7065–7072. doi:10.1158/0008-5472.CAN-04-1082
Slee EA, Adrain C, Martin SJ (2001) Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 276:7320–7326. doi:10.1074/jbc.M008363200
Wolf BB, Schuler M, Echeverri F, Green DR (1999) Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem 274:30651–30656. doi:10.1074/jbc.274.43.30651
Jänicke RU, Sohn D, Totzke G, Schulze-Osthoff K (2006) Caspase-10 in mouse or not? Science 312:1874. doi:10.1126/science.312.5782.1874a
Acknowledgment
This work was supported by the Collaborative Research Center “Extrinsic Ageing” funded by the Deutsche Forschungsgemeinschaft (SFB 728/B1).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jänicke, R.U. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 117, 219–221 (2009). https://doi.org/10.1007/s10549-008-0217-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0217-9